804912 (XEN.L) Share Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average Volume539,436 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive XEN News and Ratings via Email

Sign-up to receive the latest news and ratings for 804912 (XEN.L) and its competitors with MarketBeat's FREE daily newsletter.

About 804912 (XEN.L)

Xenetic Biosciences plc, formerly Lipoxen plc, is a holding company engaged in development of drug and vaccine delivery systems and products in fields of protein drugs, vaccines and oncology. The Company's technology platforms include PolyXen for extending efficacy and half life of biologic drugs; ImuXen for creating new vaccines and improving existing vaccines, and OncoHist for novel mode of action drugs for oncology therapies. It has drug and vaccine programs with three products in human clinical development, such as ErepoXen, which is a long-acting formulation for treatment of anaemia in both End Stage Renal Disease patients and for those undergoing chemotherapy; OncoHist, which is a recombinant human histone H1.3 molecule in Phase I clinical trials in Russia for refractory Acute Myeloid Leukaemia and Non Hodgkin's Lymphoma, and SuliXen, which is insulin for both treatment of diabetes and for central nervous system condition. On January 17, 2012, the Company acquired SymbioTec GmbH.


No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

804912 (XEN.L) (LON:XEN) Frequently Asked Questions

What stocks does MarketBeat like better than 804912 (XEN.L)?

Wall Street analysts have given 804912 (XEN.L) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but 804912 (XEN.L) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What other stocks do shareholders of 804912 (XEN.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 804912 (XEN.L) investors own include Widecells Group (WDC) and Ortac Resources (OTC).

What is 804912 (XEN.L)'s stock symbol?

804912 (XEN.L) trades on the London Stock Exchange (LON) under the ticker symbol "XEN."

How do I buy shares of 804912 (XEN.L)?

Shares of XEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Where are 804912 (XEN.L)'s headquarters?

804912 (XEN.L) is headquartered at Ste 230, 99 Hayden Ave, LONDON, 2421, United Kingdom.

How can I contact 804912 (XEN.L)?

804912 (XEN.L)'s mailing address is Ste 230, 99 Hayden Ave, LONDON, 2421, United Kingdom. The company can be reached via phone at +44-20-30211500.

This page was last updated on 9/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.